Goldman Sachs downgraded Icon (ICLR) to Neutral from Buy with a price target of $200, down from $250. While the firm continues to believe that ...
Eleven large-cap stocks were the worst performers in the ... Lekha Gupta Clinical Research Firm ICON Faces Headwinds From Top Customers And Biotech Recovery Uncertainty ICON forecasts 2025 revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback